VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018)
VitaNova Life Sciences (VNOV) posted Total Non-Current Liabilities of $12600.0 for Q3 2018, up 125.0% on a QoQ basis from $5600.0 in Q2 2018.
VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018) Analysis & Trends
VitaNova Life Sciences' Total Non-Current Liabilities history runs 2 years deep, the most recent figure standing at $12600.0 for Q3 2018.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $12600.0 in Q3 2018, while the trailing twelve-month figure through Jul 2018 was $12600.0 (changed N/A YoY) and the FY2018 annual result came in at $5600.0, down 51.72% from the prior year.
- Total Non-Current Liabilities was $12600.0 for Q3 2018 at VitaNova Life Sciences, up from $5600.0 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $12600.0 in Q3 2018 and bottomed at $5600.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -2.37 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -3.11 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 6.05 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 2,565.00 |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 279.68 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.79 Bn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 58.52 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 40.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | 12,600.00 |
| Apr 30, 2018 | 5,600.00 |
| Jan 31, 2018 | 5,600.00 |
| Oct 31, 2017 | 5,600.00 |
| Apr 30, 2017 | 11,600.00 |